Literature DB >> 2647152

Structural characterization and localization of corticotropin-releasing factor in testis.

T Audhya1, C S Hollander, D H Schlesinger, B Hutchinson.   

Abstract

To sequence and thereby definitively characterize corticotropin-releasing factor (CRF)-like material from a representative peripheral tissue, CRF was obtained from 76 ovine testes. The novel extraction procedure involved use of an immunoaffinity column to which a high-affinity CRF monoclonal antibody was attached as well as fast protein liquid chromatography. The complete sequence was elucidated by gas-phase sequencing, carboxyamidopeptidase digestion and cyanogen bromide cleavage. Aside from microheterogeneity at position 39, all the other amino acids were identical to ovine hypothalamic CRF. Additionally, in immunohistochemical studies in the rat, CRF was localized to the Leydig cell. These findings along with related observations by ourselves and others are compatible with the hypothesis that CRF plays a significant local role, possibly by paracrine or autocrine mechanisms.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2647152     DOI: 10.1016/0167-4838(89)90226-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

Review 1.  Regulation of male fertility by the opioid system.

Authors:  Nerea Subirán; Luis Casis; Jon Irazusta
Journal:  Mol Med       Date:  2011-03-16       Impact factor: 6.354

2.  Urocortins are present in the rat testis.

Authors:  Soon Lee; Brian Braden; Sang Soo Kang; Catherine Rivier
Journal:  Neuropeptides       Date:  2011-01-21       Impact factor: 3.286

Review 3.  Human endometrium as a neuroendocrine tissue: expression, regulation and biological roles of endometrial corticotropin-releasing hormone (CRH) and opioid peptides.

Authors:  E Zoumakis; A N Margioris; A Makrigiannakis; C Stournaras; A Gravanis
Journal:  J Endocrinol Invest       Date:  1997-03       Impact factor: 4.256

4.  Immunoreactive corticotropin-releasing hormone and its binding sites in the rat ovary.

Authors:  G Mastorakos; E L Webster; T C Friedman; G P Chrousos
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

5.  Presence of immunoreactive corticotropin releasing hormone in thyroid lesions.

Authors:  C D Scopa; G Mastorakos; T C Friedman; M Melachrinou; M J Merino; G P Chrousos
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

6.  Urocortin 1 inhibits rat leydig cell function.

Authors:  Catherine L Rivier
Journal:  Endocrinology       Date:  2008-08-21       Impact factor: 4.736

Review 7.  The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress.

Authors:  Sean M Smith; Wylie W Vale
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

8.  New Insights Into the Evolution of Corticotropin-Releasing Hormone Family With a Special Focus on Teleosts.

Authors:  Gersende Maugars; Xavier Mauvois; Patrick Martin; Salima Aroua; Karine Rousseau; Sylvie Dufour
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-22       Impact factor: 6.055

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.